Dates: 01/02/2021
31/07/2025
Topic: Tool
Project type: Clinic
Theranostic
Immunotherapy
Project target: Cancer Vaccines
Financing:
H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being
H2020-EU.3.1.3. – Treating and managing disease
Other
Participating agents:
ETHERNA IMMUNOTHERAPIES
Keywords: vaccine; oncoology; HPV16; RNA;
Countries: Belgium; Sweden; Netherlands
Project page: Access page
